mRNA |
masitinib |
GDSC1000 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
BMS-536924 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
Erlotinib |
GDSC1000 |
pan-cancer |
AAC |
0.015 |
0.8 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
Irinotecan |
CCLE |
pan-cancer |
AAC |
-0.017 |
0.8 |
mRNA |
chlorambucil |
CTRPv2 |
pan-cancer |
AAC |
0.0096 |
0.8 |
mRNA |
SZ4TA2 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.8 |
mRNA |
BIBW2992 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |